Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $44.5500 (2.39%) ($44.5500 - $44.5500) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.01% (three month average) | RSI | 69 | Latest Price | $44.5500(2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.3% a day on average for past five trading days. | Weekly Trend | HALO advances 2.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWM(44%) IWO(44%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.005% in a week (0% probabilities). VIXM(-24%) UUP(-11%) VXX(-8%) TBT(-4%) GLD(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.005% (StdDev 2.01%) | Hourly BBV | 2.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $43.52(2.37%) | 10 Day Moving Average | $42.67(4.41%) | 20 Day Moving Average | $41.9(6.32%) | To recent high | 0% | To recent low | 39.4% | Market Cap | $6.089b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |